Towards Healthcare
Cell-Based Immunotherapies Market Reach 15.02% CAGR by 2034

Cell-Based Immunotherapies Market Size 2025 Key Players & Future Demand Across Oncology & Solid Tumors

According to forecasts, the global Cell-Based Immunotherapies market will grow from USD 4.59 billion in 2024 to USD 18.62 billion by 2034, with an expected CAGR of 15.02%. The cell-based immunotherapies market is growing due to rising cancer incidence and increasing for personalized, targeted treatment approaches. Advanced in cell engineering and regulatory approvals are further accelerating market expansion.

Content

  • Insight Code: 5879
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

Talk to us
FAQ's

The cell-based immunotherapies market is projected to reach USD 18.62 billion by 2034, growing at a CAGR of 15.02% from 2024 to 2034.

North America is currently leading the healthcare cybersecurity market due to its well-established biotech ecosystem, growing focus on personalized medicine, and robust funding for cancer research.

The cell-based immunotherapies market includes 5 segments by therapy type, by application indication, by source of cells, by end use, and by region.

Some key players include Novartis AG, Gilead Sciences (Kite Pharma), Bristol-Myers Squibb (Juno Therapeutics), Adaptimmune Therapeutics, Fate Therapeutics, bluebird bio, Inc., Allogene Therapeutics 

Key trends include the growth due to rising cancer incidence and the increasing demand for personalized, targeted treatment approaches.

Cells are collected from the patient (or a donor), genetically modified or expanded in a lab to improve their targeting ability, and then reintroduced into the patient body to fight disease.

India Brand Equity Foundation, Food and Drug Administration, U.S. Environmental Protection Agency, European Medicines Agency, and National Medical Products Administration.
Any Questions